PubRank

A Calin

Author PubWeight™ 159.96‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991 11.66
2 A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994 11.17
3 Striking prevalence of ankylosing spondylitis in "healthy" w27 positive males and females. N Engl J Med 1975 4.25
4 Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997 4.14
5 Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 1994 4.00
6 Clinical history as a screening test for ankylosing spondylitis. JAMA 1977 3.60
7 Sex ratio in the spondyloarthropathies and its relationship to phenotypic expression, mode of inheritance and age at onset. J Rheumatol 1993 3.39
8 Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis. J Rheumatol 1999 2.12
9 Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group. J Rheumatol 1997 2.11
10 Bone loss as well as bone formation is a feature of progressive ankylosing spondylitis. Br J Rheumatol 1990 2.03
11 Reiter's syndrome. Evaluation of preliminary criteria for definite disease. Arthritis Rheum 1981 1.97
12 The hand radiograph as a diagnostic discriminant between seropositive and seronegative 'rheumatoid arthritis': a controlled study. Ann Rheum Dis 1983 1.96
13 Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis 2000 1.92
14 Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet 2001 1.82
15 Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression. J Rheumatol 2001 1.82
16 The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment. Arthritis Rheum 1998 1.80
17 HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis 1996 1.79
18 An "experimental" epidemic of Reiter's syndrome revisited. Follow-up evidence on genetic and environmental factors. Ann Intern Med 1976 1.74
19 The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Br J Rheumatol 1996 1.73
20 Total hip arthroplasty in ankylosing spondylitis: outcome in 340 patients. J Rheumatol 2001 1.71
21 Treatment of intractable rheumatoid arthritis with total lymphoid irradiation. N Engl J Med 1981 1.69
22 Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug. Arthritis Rheum 2001 1.68
23 The chronicity of symptoms and disability in Reiter's syndrome. An analysis of 131 consecutive patients. Ann Intern Med 1979 1.53
24 A new scoring system for the Bath Ankylosing Spondylitis Metrology Index (BASMI) J Rheumatol 1995 1.49
25 A genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum 1998 1.41
26 The natural history of ankylosing spondylitis: is the disease really changing? J Rheumatol 1989 1.40
27 Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet 1990 1.39
28 Increasing age at presentation for patients with ankylosing spondylitis. Ann Rheum Dis 1992 1.39
29 Atypical antineutrophil cytoplasmic antibodies in patients with ankylosing spondylitis. Br J Rheumatol 1995 1.38
30 Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV. J Rheumatol 1999 1.28
31 Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial. Rheumatology (Oxford) 1999 1.28
32 Genetic differences between B27 positive patients with ankylosing spondylitis and B27 positive healthy controls. Arthritis Rheum 1983 1.25
33 Reiter's syndrome following epidemic shigellosis. J Rheumatol 1982 1.23
34 HLA-B27: to type of not to type? Ann Intern Med 1980 1.23
35 Observer variation in grading sacroiliac radiographs in HLA-B27 positive individuals. J Rheumatol 1983 1.23
36 Selective IgA deficiency and spondyloarthropathy: a distinct disease? Ann Rheum Dis 1990 1.20
37 Is there sexual inequality in ankylosing spondylitis? A study of 498 women and 1202 men. J Rheumatol 1990 1.20
38 The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade). Rheumatology (Oxford) 2004 1.17
39 Ankylosing spondylitis in women and men: a case-control study. J Rheumatol 1983 1.15
40 The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis. Arthritis Rheum 1998 1.14
41 Search for Reiter's syndrome after an outbreak of Shigella sonnei dysentery. J Rheumatol 1980 1.13
42 Is disease severity in ankylosing spondylitis genetically determined? Arthritis Rheum 2001 1.10
43 Initiation of biological agents in patients with ankylosing spondylitis: results of a Delphi study by the ASAS Group. Ann Rheum Dis 2003 1.08
44 Non-B27 MHC associations of ankylosing spondylitis. Genes Immun 2006 1.06
45 Ankylosing spondylitis: the correlation between a new metrology score and radiology. Br J Rheumatol 1995 1.06
46 Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis. Hum Mol Genet 2000 1.05
47 Socioeconomic status in ankylosing spondylitis: relationship between occupation and disease activity. J Rheumatol 1997 1.04
48 The development and validation of a radiographic grading system for the hip in ankylosing spondylitis: the bath ankylosing spondylitis radiology hip index. J Rheumatol 2000 1.01
49 An update on the Bath Ankylosing Spondylitis Disease Activity and Functional Indices (BASDAI, BASFI): excellent Cronbach's alpha scores. J Rheumatol 1996 0.99
50 The epidemiology of spondylodiscitis in ankylosing spondylitis--a controlled study. Br J Rheumatol 1996 0.99
51 Double-bind cross-over tiral of flurbiprofen and phenylbutazone in ankylosing spondylitis. Br Med J 1974 0.99
52 Ankylosing spondylitis. Clin Rheum Dis 1985 0.99
53 New light on uveitis in ankylosing spondylitis. J Rheumatol 1991 0.99
54 The prevalence and nature of back pain in an industrial complex: a questionnaire and radiographic and HLA analysis. Spine (Phila Pa 1976) 1980 0.99
55 Fatigue in ankylosing spondylitis: its prevalence and relationship to disease activity, sleep, and other factors. J Rheumatol 1996 0.97
56 Inflammatory eye, skin, and bowel disease in spondyloarthritis: genetic, phenotypic, and environmental factors. J Rheumatol 2001 0.97
57 Letter: "Ankylosing rheumatoid arthritis", ankylosing spondylitis, and HL-A antigens. Lancet 1974 0.97
58 The natural history of ankylosing spondylitis. Does it burn out? J Rheumatol 1993 0.97
59 Willingness to accept risk in the treatment of rheumatic disease. J Epidemiol Community Health 1990 0.96
60 Efficacy of total lymphoid irradiation in intractable rheumatoid arthritis. A double-blind, randomized trial. Ann Intern Med 1985 0.94
61 Aortitis in ankylosing spondylitis: early detection of aortic root abnormalities with two dimensional echocardiography. Am J Cardiol 1982 0.94
62 Ankylosing spondylitis sine sacroiliitis. Arthritis Rheum 1979 0.93
63 Presence of circulation immune complexes in Reiter's syndrome and ankylosing spondylitis. Clin Immunol Immunopathol 1981 0.93
64 Bath Ankylosing Spondylitis Functional Index. Br J Rheumatol 1995 0.92
65 Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis. Ann Rheum Dis 1994 0.92
66 The X-chromosome and susceptibility to ankylosing spondylitis. Arthritis Rheum 2000 0.92
67 Exercise in ankylosing spondylitis: how much is optimum? J Rheumatol 1998 0.91
68 The case against seronegative rheumatoid arthritis. Am J Med 1981 0.91
69 Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis. J Rheumatol 1999 0.91
70 Reference centile charts for measures of disease activity, functional impairment, and metrology in ankylosing spondylitis. Arthritis Rheum 1998 0.90
71 Reiter's syndrome. Evaluation of preliminary criteria for definite disease. Bull Rheum Dis 1982 0.90
72 The close correlation between symptoms and disease expression in HLA B27 positive individuals. J Rheumatol 1977 0.88
73 Perception of prescription drug risks: a survey of patients with ankylosing spondylitis. J Rheumatol 1990 0.88
74 Late onset ankylosing spondylitis--a distinct disorder? Br J Rheumatol 1991 0.88
75 The changing epidemiology of rheumatic diseases: should ankylosing spondylitis now be included? Br J Rheumatol 1990 0.87
76 Sustained improvement of intractable rheumatoid arthritis after total lymphoid irradiation. Arthritis Rheum 1983 0.87
77 Reactive arthritis. Br Med J 1980 0.87
78 Analysis of the MHC class II encoded components of the HLA class I antigen processing pathway in ankylosing spondylitis. Ann Rheum Dis 1994 0.87
79 Reiter's syndrome. Med Clin North Am 1977 0.86
80 A double-blind placebo-controlled study of auranofin in patients with psoriatic arthritis. Arthritis Rheum 1989 0.86
81 Workshop III. Management of Reiter's syndrome. Ann Rheum Dis 1979 0.86
82 Raised serum creatine phosphokinase activity in ankylosing spondylitis. Ann Rheum Dis 1975 0.86
83 Low dose amitriptyline in ankylosing spondylitis: a short term, double blind, placebo controlled study. J Rheumatol 1997 0.86
84 The effect of transforming growth factor beta1 gene polymorphisms in ankylosing spondylitis. Rheumatology (Oxford) 2003 0.85
85 A case-control study of juvenile- and adult-onset ankylosing spondylitis. J Rheumatol 1983 0.84
86 Juvenile onset ankylosing spondylitis--more girls than we thought? J Rheumatol 1997 0.83
87 Porphyria cutanea tarda associated with methotrexate therapy. Br J Rheumatol 1993 0.83
88 Bacterial endocarditis presenting as acute monoarthritis. Ann Rheum Dis 1988 0.83
89 Primary ankylosing spondylitis, psoriatic and enteropathic spondyloarthropathy: a controlled analysis. J Rheumatol 1991 0.83
90 Rarity of nephropathy in ankylosing spondylitis. Arthritis Rheum 1982 0.83
91 Ankylosing spondylitis and epidemic Reiter's syndrome: genetics and environment [Proceedings]. Ann Rheum Dis 1976 0.83
92 Bronchorrhoea. Br Med J 1972 0.83
93 Ankylosing rheumatoid arthritis. Rheumatol Rehabil 1975 0.82
94 Survival, alcohol and deaths in ankylosing spondylitis. Br J Rheumatol 1998 0.82
95 Keratodermia blennorrhagica and mucocutaneous manifestations of Reiter's syndrome. Ann Rheum Dis 1979 0.81
96 Lessons from an international survey of paper cases of 10 real patients from an early arthritis clinic. CRI (Club Rhumatismes et Inflammation) Group. J Rheumatol 2001 0.81
97 Oligoarthropathy with chronic iridocyclitis--a disease only of childhood? J Rheumatol 1982 0.81
98 Arthritis in a patient with mycosis fungoides: complete remission after radiotherapy. Arthritis Rheum 1979 0.81
99 Serum keratan sulphate levels rise in rheumatoid arthritis patients, but fall in ankylosing spondylitis patients compared with normal controls. Biochem Soc Trans 1990 0.81
100 Comment on article by van der Linden et al. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1985 0.80
101 Royal National Hospital for Rheumatic Diseases--Bath. A 250th birthday party. J Rheumatol 1988 0.80
102 HLA B27 and sacroiliitis in Pima Indians--association in males only. J Rheumatol Suppl 1977 0.80
103 Therapeutic intervention in rheumatoid arthritis: a case-controlled comparison of seronegative and seropositive disease. Br J Rheumatol 1988 0.80
104 Which patients with ankylosing spondylitis derive most benefit from an inpatient management program? J Rheumatol 1997 0.80
105 Prevalence of spondyloarthritis in Terceira, Azores: a population based study. Ann Rheum Dis 2002 0.79
106 Post-Yersinia Arthritis. West J Med 1980 0.79
107 Letter: Normal frequency of HL-A B27 in aortic insufficiency. N Engl J Med 1976 0.79
108 HLA-B associations of HLA-B27 negative ankylosing spondylitis: comment on the article by Yamaguchi et al. Arthritis Rheum 1996 0.79
109 Comparison of erect and supine radiographs of the hip. Br J Rheumatol 1987 0.78
110 Clinical use of tolmetin sodium in patients with ankylosing spondylitis: a review. J Clin Pharmacol 1983 0.78
111 Can we define the outcome of ankylosing spondylitis and the effect of physiotherapy management? J Rheumatol 1994 0.77
112 Peripheral motor axons of SOD1(G127X) mutant mice are susceptible to activity-dependent degeneration. Neuroscience 2013 0.77
113 Efficacy and tolerance of a novel precision-dose formulation of indomethacin: double-blind trials in rheumatoid arthritis and osteoarthritis. Curr Med Res Opin 1983 0.77
114 Auranofin: 1 mg or 9 mg? The search for the appropriate dose. J Rheumatol Suppl 1982 0.77
115 Rheumatoid arthritis: extra-articular manifestations. Br Med J 1969 0.77
116 Osteoporosis and ankylosing spondylitis. Br J Rheumatol 1991 0.77
117 The role of germline polymorphisms in the T-cell receptor in susceptibility to ankylosing spondylitis. Br J Rheumatol 1998 0.77
118 Reactive arthropathy following Salmonella vaccination. Arthritis Rheum 1987 0.77
119 Excess deoxycorticosterone secretion from adrenocortical carcinoma. Br Med J 1974 0.76
120 Ankylosing spondylitis and the shoulder: commonly involved but infrequently disabling. J Rheumatol 2000 0.76
121 Discordance for psoriatic arthropathy in monozygotic twins. Arthritis Rheum 1979 0.76
122 X-radiation in the management of rheumatoid disease. Br J Hosp Med 1985 0.76
123 Diagnostic criteria (new and old) for the spondylarthropathies. Clin Exp Rheumatol 1987 0.75
124 Ethnic differences in ankylosing spondylitis: disease expression in Pakistan compared to Britain. J Rheumatol 1997 0.75
125 Spondyloarthropathy in Caucasians and non-Caucasians. J Rheumatol Suppl 1983 0.75
126 Adverse reactions to D-penicillamine after gold toxicity. Br Med J 1980 0.75
127 A placebo controlled, crossover study of azathioprine in Reiter's syndrome. Ann Rheum Dis 1986 0.75
128 Asymptomatic polyvascular atherosclerotic disease requires a complex management strategy--case report and review of the literature. J Med Life 2010 0.75
129 Issues in rheumatoid arthritis. Lancet 1999 0.75
130 The monitoring of patients on disease-modifying antirheumatoid drugs. Br J Rheumatol 1993 0.75
131 Neutropenia and rheumatoid arthritis. West J Med 1978 0.75
132 Nonsteroidal antiinflammatory drugs and gastrointestinal toxicity: comment on the article by Savage et al. Arthritis Rheum 1994 0.75
133 Letter: HL-A antigens and ankylosing spondylitis. Br Med J 1975 0.75
134 Maternal age and the risk of developing ankylosing spondylitis. Ann Rheum Dis 1997 0.75
135 Non-steroidal anti-inflammatory drugs and frusemide-induced diuresis. Br Med J (Clin Res Ed) 1981 0.75
136 Geode development and multiple fractures in rheumatoid arthritis. Ann Rheum Dis 1985 0.75
137 What do patients and rheumatologists regard as an 'acceptable' risk in the treatment of rheumatic disease? Br J Rheumatol 1991 0.75
138 A pair of radiologic 'red herrings'. Hosp Pract (Off Ed) 1981 0.75
139 [On the treatment of progressive myopia and its complications]. Bull Mem Soc Fr Ophtalmol 1969 0.75
140 [Association of a choroidal malignant melanoma and reticulohistiocytoma]. Bull Mem Soc Fr Ophtalmol 1976 0.75
141 High risk of sacroiliitis in HLA--B27-positive Pima Indian men. Arthritis Rheum 1982 0.75
142 The single hot joint. Compr Ther 1976 0.75
143 Ankylosing spondylitis. Comparative analysis of Swedish (n = 780) and British (n = 1500) experience--the National Ankylosing Spondylitis Societies. Scand J Rheumatol 1987 0.75
144 The elusive triad. Hosp Pract (Off Ed) 1981 0.75
145 Abuse of computed tomography. Arthritis Rheum 1982 0.75
146 [The treatment of collagen diseases]. Internist (Berl) 1980 0.75
147 Degenerative joint disease. Am Fam Physician 1986 0.75
148 Cervical spine surgery in ankylosing spondylitis: is the outcome good? Clin Rheumatol 1997 0.75
149 Pathogenesis of ankylosing spondylitis: the state of the art. Br J Rheumatol 1988 0.75
150 Differences in understanding and application of 1987 ACR criteria for rheumatoid arthritis and 1991 ESSG criteria for spondylarthropathy. A pilot survey. Clin Exp Rheumatol 2002 0.75
151 Non-steroidal anti-inflammatory drugs and joint erosions. Lancet 1981 0.75
152 Intestinal perforation associated with osmotic slow release indomethacin capsules. Br Med J (Clin Res Ed) 1984 0.75
153 In common clinical usage nonsteroidal anti-inflammatory drugs infrequently produce adverse effects on the kidney. Am J Kidney Dis 1983 0.75
154 Reiter's syndrome--1982. Clin Rheumatol 1982 0.75
155 HLA-DRw4, rheumatoid factor, and prognosis in rheumatoid arthritis. Lancet 1979 0.75
156 [Late results obtained in dacryostenosis]. Bull Mem Soc Fr Ophtalmol 1977 0.75
157 Back pain--what can we offer? Br Med J 1979 0.75
158 "Lepromatous" and "tuberculoid" rheumatoid arthritis. Lancet 1982 0.75
159 Rheumatoid arthritis. Am Fam Physician 1978 0.75
160 Familial aggregation of Reiter's syndrome and ankylosing spondylitis: a comparative study. J Rheumatol 1984 0.75
161 Postsalmonella reactive phenomena in 2 patients with ankylosing spondylitis: no modification of the underlying disease. J Rheumatol 1990 0.75
162 The treatment of intractable rheumatoid arthritis with lymphoid irradiation. Int J Radiat Oncol Biol Phys 1981 0.75
163 Modern aspirin substitutes (non-steroidal, anti-inflammatory drugs). Ration Drug Ther 1982 0.75
164 HLA-B27, rheumatoid factor and spondyloarthritis. Clin Exp Rheumatol 1997 0.75
165 Sulindac in ankylosing spondylitis. Double-blind evaluation of sulindac and indomethacin. JAMA 1979 0.75
166 HLA-B27 in 1982: reappraisal of a clinical test. Ann Intern Med 1982 0.75
167 Letter: Nonsteroidal anti-inflammatory agents. N Engl J Med 1975 0.75
168 Pain and inflammation. Am J Med 1984 0.75
169 Letter: Drug treatment of rheumatoid arthritis. Lancet 1975 0.75
170 Renal glomerular function in ankylosing spondylitis. Scand J Rheumatol 1975 0.75
171 On the reassessment of the prevalence of As among B27 positive normal individuals. J Rheumatol 1980 0.75
172 [Our experiences in hydrostatic active surgery of the anterior part of the eyeball]. Klin Monbl Augenheilkd 1971 0.75
173 Double-blind, multi-centre parallel trial of ketoprofen and ibuprofen in the treatment of rheumatoid arthritis. J Rheumatol 1977 0.75
174 Management of ankylosing spondylitis. Bull Rheum Dis 1981 0.75
175 Non-steroidal anti-inflammatory drugs and the classical arthritides: focus on five-years of piroxicam experience. Eur J Rheumatol Inflamm 1987 0.75
176 Comment on van der Linden article. Arthritis Rheum 1984 0.75
177 Therapeutic focus. Piroxicam. Br J Clin Pract 1988 0.75
178 Prognosis and natural history of Reiter's syndrome. Ann Rheum Dis 1979 0.75
179 Back pain: mechanical or inflammatory? Am Fam Physician 1979 0.75
180 HLA 27 positive, negative, or both? N Engl J Med 1980 0.75
181 Analysis of HLA-B27 antigen with monoclonal antibodies. J Rheumatol Suppl 1983 0.75
182 [Reiter's syndrome in males and females: a case-control study]. Rev Hosp Clin Fac Med Sao Paulo 1987 0.75
183 Ankylosing spondylitis and the other seronegative spondylarthritides. Compr Ther 1979 0.75
184 Allopurinol toxicity masquerading as malignancy. JAMA 1978 0.75
185 A post World War II date of birth peak in patients subsequently developing AS is unexplained. J Rheumatol 1990 0.75
186 Reiter's syndrome: evaluation of proposed criteria. Ann Rheum Dis 1979 0.75
187 [Choroid detachment in post operative complications of cataract]. Bull Mem Soc Fr Ophtalmol 1972 0.75
188 Lymphocyte proliferative responses to bacterial antigens in B27-associated arthropathies. Br J Rheumatol 1985 0.75
189 Ankylosing spondylitis: genetics versus environment. Compr Ther 1976 0.75
190 Immunology: a facet of aging. Geriatrics 1977 0.75
191 From Rome to Bath and back again. Ann Ital Med Int 1990 0.75
192 Reiter's syndrome. Lancet 1979 0.75
193 Early diagnosis of ankylosing spondylitis. Lancet 1977 0.75
194 [Periscopic device for relaxation of accommodation, adapted to the (Zeiss-Jena) coincidence refractometer]. Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol 1977 0.75
195 Seronegative spondyloarthritides. Med Clin North Am 1986 0.75
196 The management of collagen diseases. Ration Drug Ther 1980 0.75